Industry Overview of Anti-Snoring Treatment Market
IMARC Group, a leading market research company, has recently releases report titled “Anti-Snoring Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Anti-Snoring Treatment market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How Big Is The Anti-Snoring Treatment Market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 1.5 Billion |
| Market Forecast in 2028 | US$ 2.5 Billion |
| Growth rate (2023 to 2028) | CAGR of 9% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What are Anti-Snoring Treatment?
Snoring is characterized by the production of loud, disruptive sounds during breathing, resulting from the vibration of soft tissues in the throat. Medical treatment options for snoring include surgical interventions and the use of continuous positive airway pressure (CPAP). CPAP involves wearing a mask over the nose or mouth that is connected to a machine, which delivers a constant flow of air into the nostrils to keep the airway open. Lifestyle changes can also help alleviate snoring, such as maintaining a healthy body weight, addressing nasal congestion, adjusting sleep positions, and avoiding alcohol and sedating medications. These measures contribute to the reduction or elimination of snoring.
What Are The Growth Prospects And Trends In The Anti-Snoring Treatment Industry?
The market for anti-snoring treatments is primarily driven by technological advancements in supporting devices. There is a growing awareness of the long-term effects of snoring, such as fatigue, heart issues, hypertension, stroke, type 2 diabetes, and decreased oxygen levels, which contributes to market growth. The demand for anti-snoring treatments is also rising due to the recognition that loud and frequent snoring can be a sign of obstructive sleep apnea (OSA), which is linked to various health conditions including cancer, glaucoma, cognitive and behavioral disorders, and road accidents. The market is further boosted by the adoption of anti-snoring apps, behavioral therapies, dental devices, tongue stabilizing devices (TSD), and mandibular advancing devices (MAD/JAD) for the treatment of snoring. Sedentary lifestyles, unhealthy diets, tobacco and alcohol consumption, and the increasing prevalence of sleep disorders are significant factors driving the market. The anti-snoring treatment market is expected to continue growing in the coming years.
What Is Included In Market Segmentation?
The report has segmented the market into the following categories:
Breakup by Device Type:
- Mandibular Advancement Devices (MAD)
- Tongue Stabilizing Devices (TSD)
- Continuous Positive Airway Pressure (CPAP) Devices
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who Are The Key Players Operating In The Industry?
The report covers the major market players including:
- Airway Management Inc.
- Apnea Sciences Corporation
- Fisher & Paykel Healthcare Corporation Limited
- Koninklijke Philips N.V.
- MEDiTAS Ltd.
- Medtronic plc
- Mitsui Chemicals Inc.
- ResMed Inc.
- Rotech Healthcare Inc.
- SomnoMed
- The Pure Sleep Company and Tomed GmbH.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
